Arie Gutman, Dr.
Founder & CEO
Claimed by owner FineTech Pharmaceutical
Former names:
Developing Active Pharmaceutical Ingredients
Acquired by OPKO Health on Dec, 2011
FineTech Pharmaceutical
About
FineTech Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs) with the goal of bypassing process and polymorph patents. The company also offers analytical method development and patent analysis to help bring clients products to market more quickly.
FineTechs APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. The company specializes in organic processes, including multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry.
FineTech operates in six facilities on a single campus. The facility is FDA registered and the company abides by cGMP standards. Founded as FineTech Laboratories Ltd in conjunction with the Technion Israel Institute of Technology, FineTech has been acquired by OPKO Health Inc, which is controlled by Teva Pharmaceutical Industries.
FineTechs APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. The company specializes in organic processes, including multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry.
FineTech operates in six facilities on a single campus. The facility is FDA registered and the company abides by cGMP standards. Founded as FineTech Laboratories Ltd in conjunction with the Technion Israel Institute of Technology, FineTech has been acquired by OPKO Health Inc, which is controlled by Teva Pharmaceutical Industries.
Primary Sector
Life Sciences & HealthTech
Products
Latanoprost, Cabergoline, Methylbenzethonium chloride, Nabilone, Travoprost, Bimatoprost
Geographic markets
Canada, Israel, United States, Europe
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
0
Investors
0
The Team
(2)
AGD
IFD
Irina Fedotev, Dr.
GM
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
M&A
EXIT
$27.5M
Dec 2011
Type
Acquisition
Was acquired by
OPKO Health
$27.5M
Media gallery
(0)Locations
Israel
HaNarkisim St 33, Nesher, Israel
Locations
Israel
HaNarkisim St 33, Nesher, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,